Health ❯ Healthcare ❯ Drug Approval

FDA Regulations

Global Health Initiatives Psychedelic Drugs Epinephrine Products Accelerated Approval Process Oral Medications Cannabis Products Leqembi Injection GLP-1 Drugs Clinical Research Obesity Drugs Biologics License Application Label Expansion First-in-Class Therapies

3 ARTICLES

3w ago

Amgen’s Dazodalibep Meets Primary Goal in Phase 3 Sjögren’s Trial

The topline result raises the prospect of the first FDA‑approved therapy for Sjögren’s disease, with full data and a second Phase 3 readout determining approval chances.

3 ARTICLES

6mo ago

Summit Therapeutics Shares Rally as Ivonescimab Trials Near Q2 Readout

3 ARTICLES

8mo ago

Biogen Guides 2026 Profit Above Estimates on Cost Cuts and Leqembi Momentum

9 ARTICLES

last yr.

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial